Merlion Pharma

Last updated: 13.02.2014

Address: 41 Science Park Road, #04-03B The Gemini,Singapore Science Park II,Singapore 117610,Singapore

Tel: +(65) 6829-5600


Company description

MerLion Pharmaceuticals Pte Ltd was formed in 2002 through the privatisation of the former Centre for Natural Product Research (CNPR), a unique unit of Singapore’s Institute of Molecular and Cell Biology (IMCB). MerLion Pharma acquired all of CNPR’s assets, including its unique collection of natural product samples. The company is now focused on developing its lead antibacterial candidate, finafloxacin.

Products and services

MerLion Pharma is progressing finafloxacin, a novel, highly differentiated antibacterial candidate. The compound, which has already shown potential for the treatment of urinary tract infections and the eradication of Helicobacter pylori, is being evaluated in critical care and hospital indications


We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here